Our new immunotherapy book has been published by Springer:
I want to take a moment to acknowledge the stunning group of authors who made the book a success. I’d also like to promote our fund raising effort in memory of Holbrook Kohrt, to whom the volume is dedicated – 5% of net sales will be donated by me, on behalf of all of our authors, the the Cancer Research Institute in New York. So please consider buying the book or just the chapters you want (they can be purchased individually through the link given above.
Now, the authors:
from Arlene Sharpe and her lab (Harvard Medical School, Boston):
Enhancing the Efficacy of Checkpoint Blockade Through Combination Therapies
Parallel Costimulation of Effector and Regulatory T Cells by OX40, GITR, TNFRSF25, CD27, and CD137: Implications for Cancer Immunotherapy
NK Cell Responses in Immunotherapy: Novel Targets and Applications